Ensign Peak Advisors, Inc Repare Therapeutics Inc. Transaction History

Ensign Peak Advisors, Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$8.16 - $13.01 $599,148 - $955,259	73,425 Added 27.1%	344,328 $4.16 Million
Q2 2023 Aug 14, 2023	BUY	$8.63 - $12.53 $1.61 Million - $2.33 Million	186,300 Added 220.2%	270,903 $2.87 Million
Q4 2022 Feb 13, 2023	SELL	$12.5 - $18.13 $77,500 - $112,406	-6,200 Reduced 6.83%	84,603 $1.24 Million
Q3 2022 Nov 14, 2022	BUY	$11.57 - $15.59 $63,403 - $85,433	5,480 Added 6.42%	90,803 $1.1 Million
Q2 2022 Aug 12, 2022	SELL	$8.45 - $14.84 $236,354 - $415,089	-27,971 Reduced 24.69%	85,323 $1.19 Million
Q1 2022 May 16, 2022	BUY	$11.38 - $21.88 $238,638 - $458,823	20,970 Added 22.71%	113,294 $1.61 Million
Q4 2021 Feb 11, 2022	BUY	$19.66 - $28.11 $1.43 Million - $2.05 Million	72,924 Added 375.9%	92,324 $1.95 Million
Q3 2020 Nov 12, 2020	BUY	$21.55 - $33.92 $374,970 - $590,208	17,400 Added 870.0%	19,400 $597,000
Q2 2020 Aug 12, 2020	BUY	$30.8 - $32.99 $61,600 - $65,980	2,000 New	2,000 $62,000

35.4M

50K

300

Ticker RPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,937,800
Market Cap $56.6M
Description
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.